News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

The Human Cancer Models Initiative’s (HCMI’s) Searchable Catalog now has new features that allow users to easily locate models and their case-associated data in the Genomic Data Commons.

NCI’s Office of Cancer Genomics’ data analysis and experimental observations tool—CTD² Dashboard—aims to make cancer-relevant results from the CTD² Network easier to use. Learn more about recent improvements to the Dashboard.

In a recent blog post, Center for Cancer Genomics Director, Dr. Louis Staudt, shares highlights from two journal articles describing NCI’s Genomic Data Commons (GDC). In seven years, the GDC has grown from a vision to a massive, interactive data system with genomic data processing pipelines for all types of researchers to use.

NCI is offering administrative supplements for the adaptation and repackaging of existing broad-based visualization methods that have the potential to make Cancer Moonshot-aligned data more explorable and interpretable by the broader cancer research community.

NCI is pleased to announce that, moving forward, ITCR funding opportunities will allow the use of URLs and hyperlinks in applications.

In 1971, the National Cancer Act was signed into law, creating NCI. Now, 50 years later, NCI celebrates the progress that has been made and the promise of what’s to come.

NCI seeks input to identify promising opportunities and cancer research needs that, while difficult to address on an individual scale, might be directly related to the scientific mission of a national lab. Responses will be accepted through Friday, February 19, 2021.

New pancreatic cancer data sets are now available through the NCI Genomic Data Commons, Proteomic Data Commons, and The Cancer Imaging Archive.

Applications are now being accepted for the NCI-DOE Collaboration Workshop Series on radiation oncology. Join multidisciplinary experts from basic science, clinical practice, and computational science to explore emerging and futuristic opportunities to advance radiation therapy.

Clinical plasma samples and associated clinical data collected from breast cancer patients by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) are now publicly available research resources.